SC
ORGO icon

Savant Capital’s Organogenesis Holdings ORGO Stock Holding History

Savant Capital’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-64,623
Closed -$207K – 1328
2024
Q4 		$207K Hold
64,623
– – ﹤0.01% 1310
2024
Q3 		$185K Buy
64,623
+19,715
+44% +$55.3K ﹤0.01% 1292
2024
Q2 		$126K Buy
+44,908
New +$121K ﹤0.01% 1185

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Savant Capital's ORGO Position: Q1 2025 in Review

Savant Capital sold out of Organogenesis Holdings (ORGO) in Q1 2025, closing a stake of 64,623 shares — an estimated $207K sold.

Savant Capital first reported a position in ORGO in Q2 2024 and held it in 3 quarters. The position peaked at $207K in Q4 2024. 136 funds tracked by Wall St. Rank hold ORGO as of Q1 2025.

  • Savant Capital reported no remaining Organogenesis Holdings position as of Q1 2025 after selling out during the quarter.
  • Savant Capital sold 64,623 Organogenesis Holdings shares in Q1 2025, an estimated $207K.
  • Savant Capital first reported a position in Organogenesis Holdings in Q2 2024 and held it in 3 quarters.
  • Savant Capital's Organogenesis Holdings position peaked at $207K in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2025.

Based on Savant Capital's 13F filing for Q1 2025, filed 8 May 2025.